HK Stock MarketDetailed Quotes

01830 PERFECT MEDICAL

Watchlist
  • 2.200
  • -0.020-0.90%
Market Closed Dec 27 16:08 CST
2.76BMarket Cap9.52P/E (TTM)

PERFECT MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Sep 30, 2024
(FY)Mar 31, 2024
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(Q6)Sep 30, 2021
(FY)Mar 31, 2021
(Q6)Sep 30, 2020
(FY)Mar 31, 2020
Turnover
-13.63%620.27M
0.29%1.39B
7.46%718.15M
2.91%1.39B
-16.63%668.3M
23.88%1.35B
57.24%801.64M
-12.18%1.09B
-28.00%509.81M
3.67%1.24B
Operating income
-13.63%620.27M
0.29%1.39B
7.46%718.15M
2.91%1.39B
-16.63%668.3M
23.88%1.35B
57.24%801.64M
-12.18%1.09B
-28.00%509.81M
3.67%1.24B
Operating expenses
Gross profit
Selling expenses
9.63%-77.24M
-5.80%-159.6M
-9.98%-85.47M
17.40%-150.85M
26.05%-77.72M
-19.15%-182.63M
-44.09%-105.1M
-12.05%-153.28M
-0.19%-72.94M
19.11%-136.79M
Administrative expenses
3.30%-14.49M
-27.84%-8.16M
-69.22%-14.98M
3.13%-6.38M
-605.58%-8.86M
-161.99%-6.59M
-130.70%-1.26M
84.37%-2.52M
93.93%-544K
---16.09M
Employee expense
8.63%-217.6M
-0.23%-471.65M
-3.27%-238.15M
-14.03%-470.57M
3.77%-230.61M
-18.87%-412.68M
-45.59%-239.65M
2.52%-347.16M
11.31%-164.6M
-4.52%-356.14M
Depreciation and amortization
10.85%-91.54M
9.67%-201.96M
10.02%-102.68M
-2.08%-223.59M
-11.46%-114.12M
-27.91%-219.05M
-25.30%-102.38M
-10.61%-171.26M
-14.49%-81.71M
-119.95%-154.82M
Special items of operating profit
18.70%-60.92M
-19.59%-169.59M
-49.99%-74.93M
-3.87%-141.81M
36.32%-49.96M
-174.88%-136.52M
-328.20%-78.45M
58.92%-49.67M
71.70%-18.32M
44.27%-120.91M
Operating profit
-21.52%158.48M
-3.45%382.38M
7.96%201.93M
0.91%396.06M
-31.94%187.05M
7.27%392.5M
60.06%274.82M
-19.79%365.89M
-43.63%171.69M
14.09%456.2M
Financing income
-21.37%1.44M
58.76%12.57M
129.96%1.83M
352.80%7.92M
---6.12M
--1.75M
----
----
----
----
Financing cost
----
10.37%-11.22M
----
22.20%-12.52M
----
-108.19%-16.1M
-340.99%-7.07M
-37.65%-7.73M
52.38%-1.6M
-233.90%-5.62M
Earning before tax
-21.52%159.92M
-1.98%383.72M
12.63%203.77M
3.52%391.46M
-32.43%180.92M
5.58%378.15M
57.42%267.75M
-20.51%358.16M
-43.53%170.09M
11.51%450.58M
Tax
23.54%-28.58M
3.29%-73.32M
-23.49%-37.37M
-3.99%-75.82M
41.04%-30.27M
0.84%-72.91M
-48.99%-51.33M
18.68%-73.53M
40.94%-34.45M
-6.35%-90.42M
After-tax profit from continuing operations
-21.06%131.34M
-1.66%310.4M
10.44%166.39M
3.40%315.64M
-30.38%150.66M
7.24%305.25M
59.56%216.41M
-20.97%284.63M
-44.16%135.64M
12.89%360.16M
Earning after tax
-21.06%131.34M
-1.66%310.4M
10.44%166.39M
3.40%315.64M
-30.38%150.66M
7.24%305.25M
59.56%216.41M
-20.97%284.63M
-44.16%135.64M
12.89%360.16M
Minority profit
---9.5M
---5.4M
----
----
----
----
----
----
----
----
Profit attributable to shareholders
-15.35%140.84M
0.05%315.8M
10.44%166.39M
3.40%315.64M
-30.38%150.66M
7.24%305.25M
59.56%216.41M
-20.97%284.63M
-44.16%135.64M
12.89%360.16M
Basic earnings per share
-15.15%0.112
-0.79%0.251
9.09%0.132
2.02%0.253
-31.64%0.121
2.06%0.248
46.28%0.177
-24.53%0.243
-44.50%0.121
11.42%0.322
Diluted earnings per share
-15.15%0.112
-0.79%0.251
9.09%0.132
2.02%0.253
-31.64%0.121
2.06%0.248
46.28%0.177
-24.30%0.243
-44.24%0.121
11.85%0.321
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(Q6)Sep 30, 2024(FY)Mar 31, 2024(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(Q6)Sep 30, 2021(FY)Mar 31, 2021(Q6)Sep 30, 2020(FY)Mar 31, 2020
Turnover -13.63%620.27M0.29%1.39B7.46%718.15M2.91%1.39B-16.63%668.3M23.88%1.35B57.24%801.64M-12.18%1.09B-28.00%509.81M3.67%1.24B
Operating income -13.63%620.27M0.29%1.39B7.46%718.15M2.91%1.39B-16.63%668.3M23.88%1.35B57.24%801.64M-12.18%1.09B-28.00%509.81M3.67%1.24B
Operating expenses
Gross profit
Selling expenses 9.63%-77.24M-5.80%-159.6M-9.98%-85.47M17.40%-150.85M26.05%-77.72M-19.15%-182.63M-44.09%-105.1M-12.05%-153.28M-0.19%-72.94M19.11%-136.79M
Administrative expenses 3.30%-14.49M-27.84%-8.16M-69.22%-14.98M3.13%-6.38M-605.58%-8.86M-161.99%-6.59M-130.70%-1.26M84.37%-2.52M93.93%-544K---16.09M
Employee expense 8.63%-217.6M-0.23%-471.65M-3.27%-238.15M-14.03%-470.57M3.77%-230.61M-18.87%-412.68M-45.59%-239.65M2.52%-347.16M11.31%-164.6M-4.52%-356.14M
Depreciation and amortization 10.85%-91.54M9.67%-201.96M10.02%-102.68M-2.08%-223.59M-11.46%-114.12M-27.91%-219.05M-25.30%-102.38M-10.61%-171.26M-14.49%-81.71M-119.95%-154.82M
Special items of operating profit 18.70%-60.92M-19.59%-169.59M-49.99%-74.93M-3.87%-141.81M36.32%-49.96M-174.88%-136.52M-328.20%-78.45M58.92%-49.67M71.70%-18.32M44.27%-120.91M
Operating profit -21.52%158.48M-3.45%382.38M7.96%201.93M0.91%396.06M-31.94%187.05M7.27%392.5M60.06%274.82M-19.79%365.89M-43.63%171.69M14.09%456.2M
Financing income -21.37%1.44M58.76%12.57M129.96%1.83M352.80%7.92M---6.12M--1.75M----------------
Financing cost ----10.37%-11.22M----22.20%-12.52M-----108.19%-16.1M-340.99%-7.07M-37.65%-7.73M52.38%-1.6M-233.90%-5.62M
Earning before tax -21.52%159.92M-1.98%383.72M12.63%203.77M3.52%391.46M-32.43%180.92M5.58%378.15M57.42%267.75M-20.51%358.16M-43.53%170.09M11.51%450.58M
Tax 23.54%-28.58M3.29%-73.32M-23.49%-37.37M-3.99%-75.82M41.04%-30.27M0.84%-72.91M-48.99%-51.33M18.68%-73.53M40.94%-34.45M-6.35%-90.42M
After-tax profit from continuing operations -21.06%131.34M-1.66%310.4M10.44%166.39M3.40%315.64M-30.38%150.66M7.24%305.25M59.56%216.41M-20.97%284.63M-44.16%135.64M12.89%360.16M
Earning after tax -21.06%131.34M-1.66%310.4M10.44%166.39M3.40%315.64M-30.38%150.66M7.24%305.25M59.56%216.41M-20.97%284.63M-44.16%135.64M12.89%360.16M
Minority profit ---9.5M---5.4M--------------------------------
Profit attributable to shareholders -15.35%140.84M0.05%315.8M10.44%166.39M3.40%315.64M-30.38%150.66M7.24%305.25M59.56%216.41M-20.97%284.63M-44.16%135.64M12.89%360.16M
Basic earnings per share -15.15%0.112-0.79%0.2519.09%0.1322.02%0.253-31.64%0.1212.06%0.24846.28%0.177-24.53%0.243-44.50%0.12111.42%0.322
Diluted earnings per share -15.15%0.112-0.79%0.2519.09%0.1322.02%0.253-31.64%0.1212.06%0.24846.28%0.177-24.30%0.243-44.24%0.12111.85%0.321
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Aesthetic Medicine
Aesthetic Medicine
Intraday-0.78%